NYSE - Nasdaq Real Time Price USD

Stride, Inc. (LRN)

62.60 +4.40 (+7.55%)
As of 12:35 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 4444
Avg. Estimate 1.150.24.244.71
Low Estimate 1.020.164.024.56
High Estimate 1.230.294.444.91
Year Ago EPS 1.010.112.974.24

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 3344
Avg. Estimate 527.59M521.53M2.02B2.17B
Low Estimate 520.15M505.7M2.02B2.13B
High Estimate 539.53M552.68M2.03B2.26B
Year Ago Sales 483.49M--1.84B2.02B
Sales Growth (year/est) 9.10%--10.10%7.30%

Earnings History

CURRENCY IN USD 6/30/2023 9/30/2023 12/31/2023 3/31/2024
EPS Est. 0.87-0.351.311.43
EPS Actual 1.010.111.541.6
Difference 0.140.460.230.17
Surprise % 16.10%131.40%17.60%11.90%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 1.150.24.244.71
7 Days Ago 1.150.24.244.71
30 Days Ago 1.150.24.244.71
60 Days Ago 1.150.24.244.71
90 Days Ago 1.150.174.094.57

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD LRNIndustrySectorS&P 500
Current Qtr. 13.90%----0.30%
Next Qtr. 81.80%----9.80%
Current Year 42.80%----4.50%
Next Year 11.10%----13.40%
Next 5 Years (per annum) 20.00%----11.06%
Past 5 Years (per annum) 29.27%------

Research Analysis

Analyst Price Targets

65.00
71.75 Average
62.60 Current
75.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 4/24/2024
Maintains Barrington Research: Outperform to Outperform 4/17/2024
Maintains Citigroup: Buy to Buy 1/29/2024
Maintains BMO Capital: Outperform to Outperform 1/25/2024
Maintains Morgan Stanley: Equal-Weight to Equal-Weight 1/24/2024
Maintains Barrington Research: Outperform to Outperform 1/24/2024

Related Tickers